{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:40:16Z","timestamp":1778910016483,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.1007\/s11882-003-0070-1","type":"journal-article","created":{"date-parts":[[2007,6,4]],"date-time":"2007-06-04T16:24:51Z","timestamp":1180974291000},"page":"378-384","source":"Crossref","is-referenced-by-count":11,"title":["Immune disorders caused by defects in the caspase cascade"],"prefix":"10.1007","volume":"3","author":[{"given":"Jennifer M.","family":"Puck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"70_CR1","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","volume":"81","author":"GH Fisher","year":"1995","unstructured":"Fisher GH, Rosenberg FJ, Straus SE, et al.: Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995, 81:935\u2013946.","journal-title":"Cell"},{"key":"70_CR2","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.7539157","volume":"268","author":"F Rieux-Laucat","year":"1995","unstructured":"Rieux-Laucat F, Le Deist F, Hivroz C, et al.: Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995, 268:1347\u20131349.","journal-title":"Science"},{"key":"70_CR3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1182\/blood.V98.1.194","volume":"98","author":"SE Straus","year":"2001","unstructured":"Straus SE, Jaffe ES, Puck JM, et al.: The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 2001, 98:194\u2013200. This paper demonstrates the elevated risk for patients with ALPS to develop lymphomas of diverse histology.","journal-title":"Blood"},{"key":"70_CR4","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/302333","volume":"64","author":"CE Jackson","year":"1999","unstructured":"Jackson CE, Hsu AP, Fischer RE. et al.: Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. Am J Hum Genet 1999, 64:1002\u20131014. This manuscript displays the spectrum of ALPS type Ia mutations, highlighting the dominant nature of in vitro apoptosis defects while exploring the genotype\/phenotype variation underlying differences in severity and penetrance.","journal-title":"Am J Hum Genet"},{"key":"70_CR5","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJM199611283352204","volume":"335","author":"J Drappa","year":"1996","unstructured":"Drappa J, Vaishnaw AK, Sullivan KE, et al.: Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med 1996, 335:1643\u20131649.","journal-title":"N Engl J Med"},{"key":"70_CR6","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1182\/blood.V89.4.1341","volume":"89","author":"MC Sneller","year":"1997","unstructured":"Sneller MC, Wang J, Dale JK, et al.: Clinical, immunologic and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood 1997, 89:1341\u20131348.","journal-title":"Blood"},{"key":"70_CR7","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0022-3476(98)70102-7","volume":"133","author":"AJ Infante","year":"1998","unstructured":"Infante AJ, Britton HA, DiNapoli T, et al.: The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome (ALPS) due to a Fas mutation that impairs lymphocyte apoptosis. J Pediatr 1998, 133:629\u2013633.","journal-title":"J Pediatr"},{"key":"70_CR8","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1172\/JCI118892","volume":"98","author":"J Wu","year":"1996","unstructured":"Wu J, Wison J, He J, et al.: Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest 1996, 98:1107\u20131113.","journal-title":"J Clin Invest"},{"key":"70_CR9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0092-8674(00)80605-4","volume":"98","author":"J Wang","year":"1999","unstructured":"Wang J, Zheng L, Lobito A, et al.: Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 1999, 98:47\u201358. This is the first demonstration of human disorders associated with caspase-10 defects; it also defines the cellular impairments in apoptosis of both T cells and dendritic cells caused by dominant mutations of caspase-10.","journal-title":"Cell"},{"key":"70_CR10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature01063","volume":"419","author":"HJ Chun","year":"2002","unstructured":"Chun HJ, Zheng L, Ahmad M, et al.: Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 2002, 419:395\u2013399. This is the first demonstration of an immunodeficiency and apoptosis disorder in two siblings with a homozygous defect in caspase-8; the importance of this paper is the linking of caspase-8 to activation functions of NK and T cells in addition to the known role of caspase-8 in apoptosis.","journal-title":"Nature"},{"key":"70_CR11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.1373520","volume":"256","author":"DP Cerretti","year":"1992","unstructured":"Cerretti DP, Kozlosky CJ, Mosley B, et al.: Molecular cloning of the interleukin-1-beta converting enzyme. Science 1992, 256:97\u2013100.","journal-title":"Science"},{"key":"70_CR12","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/356768a0","volume":"356","author":"NA Thornberry","year":"1992","unstructured":"Thornberry NA, Bull HG, Calaycay JR, et al.: A novel heterodimeric cysteine protease is required for interleukin-1-beta processing in monocytes. Nature 1992, 356:768\u2013774.","journal-title":"Nature"},{"key":"70_CR13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0968-0004(97)01085-2","volume":"8","author":"DW Nicholson","year":"1997","unstructured":"Nicholson DW, Thornberry NA: Caspases: killer proteases. Trend Biochem Sci 1997, 8:299\u2013306.","journal-title":"Trend Biochem Sci"},{"key":"70_CR14","unstructured":"Johns Hopkins University and National Center for Biotechnology Information: Online Mendelian Inheritance in Man, OMIM. http:\/\/www.ncbi.nlm.nih.gov\/omim\/ This is an outstanding comprehensive and continuously updated resource for information and references on human disease genes."},{"key":"70_CR15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1097-2765(02)00482-3","volume":"9","author":"Y Shi","year":"2002","unstructured":"Shi Y: Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 2002, 9:459\u2013470.","journal-title":"Mol Cell"},{"key":"70_CR16","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/sj.cdd.4400783","volume":"7","author":"SJ Korsmeyer","year":"2000","unstructured":"Korsmeyer SJ, Wei MC, Saito M, et al.: Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Diff 2000, 7:1166\u20131173.","journal-title":"Cell Death Diff"},{"key":"70_CR17","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(00)81265-9","volume":"85","author":"MP Boldin","year":"1996","unstructured":"Boldin MP, Goncharov TM, Goltsev YV, et al.: Involvement of MACH, a novel MORT1\/FADD-interacting protease, in Fas\/ APO-1- and TNF receptor-induced cell death. Cell 1996, 85:803\u2013815.","journal-title":"Cell"},{"key":"70_CR18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1097-2765(03)00054-6","volume":"11","author":"EN Shoizaki","year":"2003","unstructured":"Shoizaki EN, Chai J, Rigotti DJ, et al.: Mechanism of XIAPmediated inhibition of caspase-9. Mol Cell 2003, 11:519\u2013527.","journal-title":"Mol Cell"},{"key":"70_CR19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1101\/gad.13.3.239","volume":"13","author":"QL Deveraux","year":"1999","unstructured":"Deveraux QL, Reed JC: IAP family proteins: suppressors of apoptosis. Genes Dev 1999, 13:239\u2013252.","journal-title":"Genes Dev"},{"key":"70_CR20","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1126\/science.7535475","volume":"267","author":"K Kuida","year":"1995","unstructured":"Kuida K, Lippke JA, Ku G, et al.: Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 1995, 267:2000\u20132003.","journal-title":"Science"},{"key":"70_CR21","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1101\/gad.12.9.1304","volume":"12","author":"L Bergeron","year":"1998","unstructured":"Bergeron L, Perez GI, Macdonald G, et al.: Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev 1998, 12:1304\u20131314.","journal-title":"Genes Dev"},{"key":"70_CR22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0092-8674(00)81476-2","volume":"94","author":"K Kuida","year":"1998","unstructured":"Kuida K, Haydar TF, Kuan CY, et al.: Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 1998, 94:325\u2013337.","journal-title":"Cell"},{"key":"70_CR23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0092-8674(00)81477-4","volume":"94","author":"R Hakem","year":"1998","unstructured":"Hakem R, Hakem A, Duncan GS, et al.: Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 1998, 94:339\u2013352.","journal-title":"Cell"},{"key":"70_CR24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1074-7613(00)80609-3","volume":"9","author":"EE Vafolomeev","year":"1998","unstructured":"Vafolomeev EE, Schuchmann M, Luria V, et al.: Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors Fas\/Apo-1 and DR3 and is lethal prenatally. Immunity 1998, 9:267\u2013276.","journal-title":"Immunity"},{"key":"70_CR25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1242\/jcs.113.5.753","volume":"113","author":"J Wang","year":"2000","unstructured":"Wang J, Lenardo MJ: Roles of caspases in apoptosis, development and cytokine maturation revealed by homozygous gene deficiencies. J Cell Sci 2000, 113:753\u2013757.","journal-title":"J Cell Sci"},{"key":"70_CR26","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0002-9440(10)65742-2","volume":"153","author":"MS Lim","year":"1998","unstructured":"Lim MS, Straus SE, Dale JK, et al.: Pathological findings in human autoimmune lymphoproliferative syndrome. Am J Pathol 1998, 153:1541\u20131550.","journal-title":"Am J Pathol"},{"key":"70_CR27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/1096-8652(200007)64:3<214::AID-AJH14>3.0.CO;2-T","volume":"64","author":"BS Fang","year":"2000","unstructured":"Fang BS, Sneller MC, Straus SE, et al.: Report of a factor VIII inhibitor in a patient with autoimmune lymphoproliferative syndrome. Am J Hematol 2000, 64:214\u2013217.","journal-title":"Am J Hematol"},{"key":"70_CR28","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1182\/blood.V95.6.2184.2184","volume":"95","author":"K Gronbaek","year":"2000","unstructured":"Gronbaek K, Dalby T, Zeuthen J, et al.: The V410I (G1228A) variant of the caspase-10 gene is a common polymorphism of the Danish population. Blood 2000, 95:2184\u20132185. This paper shows that there are genetic variants of caspase-10 in the general population. Although not disease-associated in the heterozygous state, these variants might act in conjunction with other risk factors to have functional significance in individuals who are predisposed to autoimmune diseases.","journal-title":"Blood"},{"key":"70_CR29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1006\/geno.2000.6392","volume":"71","author":"S Hadano","year":"2001","unstructured":"Hadano S, Yanagisawa Y, Skaug J, et al.: Cloning and characterization of three novel genes, ALS2CR1, ALS2CR2, and ALS2CR3, in the juvenile amyotrophic lateral sclerosis (ALS2) critical region at chromosome 2q33-q34: Candidae genes for ALS2. Genomics 2001, 71:200\u2013213.","journal-title":"Genomics"},{"key":"70_CR30","doi-asserted-by":"crossref","first-page":"13884","DOI":"10.1073\/pnas.241358198","volume":"98","author":"J Wang","year":"2001","unstructured":"Wang J, Chun HJ, Wong W, et al.: Caspase-10 is an initiator caspase in death receptor signaling. Proc Nat Acad Sci USA 2001, 98:13884\u201313888. This paper uses primary cells with caspase-8 deficiency to prove that caspase-10, in the absence of caspase-8, can initiate the apoptotis response.","journal-title":"Proc Nat Acad Sci USA"},{"key":"70_CR31","doi-asserted-by":"crossref","unstructured":"Sprick MR, Rieser E, Stahl H, et al.: Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signaling complexes in a FADD-dependent manner but cannot functionally substitute caspase-8. EMBO J 2002, 4520\u20134530. This study probes similarities and differences between caspase-8 and caspase-10; although each can be recruited to cytoplasmic domains of death receptors and can initiate apoptosis, their functions are not completely overlapping.","DOI":"10.1093\/emboj\/cdf441"},{"key":"70_CR32","first-page":"5897","volume":"62","author":"K Harada","year":"2002","unstructured":"Harada K, Toyooka S, Shivapurkar N, et al.: Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. Cancer Res 2002, 62:5897\u20135901.","journal-title":"Cancer Res"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-003-0070-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-003-0070-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-003-0070-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T15:28:45Z","timestamp":1628954925000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-003-0070-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["70"],"URL":"https:\/\/doi.org\/10.1007\/s11882-003-0070-1","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9]]}}}